thin-layer chromatography, Fourier-transform infrared spectroscopy, and mass spectroscopy indicate that the inactivator is 5-amino-3-aza-2,2,5-trimethylhexanol. This compound, even in trace amounts (<0.05% on a molar basis), is shown to inactivate alkaline phosphatase.
Most clinical laboratories determining the activity of alkaline phosphatase (EC 3.1.3.1; orthophosphoric monoester phosphohydrolase [alkaline optimum]) in human serum use 4-nitrophenyl phosphate as substrate and an amino alcohol buffer as a transphosphorylatable acceptor (1) . Impurities in all components of this reaction system contribute to assay variability (1) (2) (3) (4) (5) . The identification of monoethanolamine, an inhibitor of alkaline phosphatase activity, as a contaminant in some preparations of diethanolamine has discouraged use of diethanolamine for phosphatase assays (4-7), and 2A2M1P' has been suggested as a preferable buffer (6, 7) . However, some preparations of 2A2M1P also contain an impurity that diminishes alkaline phosphatase activity (3, (8) (9) (10) (11) (12) (13) .
Previous communications
from this laboratory (8) (9) (10) have demonstrated that this impurity probably affects the metal ion status of the enzyme and leads to a time-dependent inactivation. This has since been confirmed in other laboratories (14) (15) (16) .
We have also presented evidence that metal ion contamination, although often resulting in strong inhibition, is not the likely source of contamination (17) . In this paper we characterize the nature and mode of inhibition of endogenous inhibitor(s) in 2A2M1P and present evidence to suggest that the major contaminant leading to enzyme inactivation is 5-amino-3-aza-2,2,5-trimethylhexanol (AATMH). 
Materials and Methods

Chemicals.
The following were purchased from Sigma Chemical Co., St Impurities in 2A2M1P were concentrated by either ionexchange or extraction with chloroform. Amberlite CG-120 resin was washed as described above, and 10 g of resin was added to 100 mL of 2A2M1P (900 mmol/L, pH 10.5) and mixed overnight. The mixture was then centrifuged and decanted. The resin was washed with 20 mL of distilled water, extracted with 5 mL of NaOH (5 mol/L), and mixed with two volumes of NaHCO3 (0.1 mol/L); the pH was adjusted to 8.8 with HC1. Chloroform extractions were performed by mixing 15 g of undiluted 2A2M1P with 100 mL of distilled water and 20 mL of chloroform and shaking overnight. 
Results
Demonstration and Characterization of an
Inactivator in 2A2MIP This instability was further characterized by examining the time-dependent decrease in activity when a pooled patient serum was preincubated with 2A2M1P (900 mmol/L, pH 10.5). Activity decreased slightly (<5%) with time with lots 1 and 4-7 over a 30-mm period ( Figure 1 , lot 7). Activity decreased in a first-order fashion with lots 2 and 3; apparent first-order decay constants and t112 for all three lots are given in Figure 1 .
In the two lots containing inactivator, activities were highest with the specimen-initiated reaction.
The increase in absorbance at 404 nm was within normal criteria for linearity (±2%) in these assays over the first 5 mm of the reaction. Therefore the presence of substrate (4-nitrophenyl phosphate) protected against the inactivation by contaminants in these two lots of 2A2M1P.
We interpret this time-dependent, substrate-protected inactivation to be related to the metal ion requirements of the enzyme: Zn2+ and/or Mg2+ We have previously demonstrated that contaminant metal ions, although possible inhibitors of alkaline phosphatase, are not the source of the inactivation due to contamination of 2A2M1P (17) . We therefore examined the preparations of 2A2M1P for a soluble organic contaminant which binds or chelates enzyme-affecting metal ions.
Effect of Zn2+ on enzyme inactivation.
Many compounds inhibit and inactivate alkaline phosphatase through chelation of enzyme-bound Zn2 (23, 24) . We therefore added Zn2 at 300 zmol per liter of 2A2M1P solution (900 mmol/L, pHm #{176}c 10.5) and determined its effects on enzyme activity. With lots 2 and 3, with which the enzyme was most labile, added Zn2 increased stability; with all other lots Zn2 was inhibitory. Zn2+ was then added at concentrations ranging from 0 to 1515 zmol/L to two representative preparations of 2A2M1P: and lot 7 (noninactivating).
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The concentrations of Zn2+ in these solutions were verified by atomic absorption spectroscopy to be within ±1% of the expected values. To 50-mL portions of each Zn2-2A2M1P solution 500 mg of Chelex-100 was added and mixed well, resulting in a duplicate set of solutions from which excess Zn2+ had been -J -.. The increased residual Zn24 in lot 3 suggests the presence of a soluble chelator that competes with Chelex for available Zn24. When the alkaline phosphatase activities of three serum pools were determined with these solutions, exogenous Zn2+ was inhibitory at all concentrations of lot 7 ( Figure 3 ). Addition of Zn24 followed by Chebex treatment of these solutions resulted in alkaline phosphatase activity equal to or greater than that measured with the untreated preparation ( Figure   3A ).
Addition of exogenous Zn24 resulted in greater measured activity in lot 3, with maximum activity obtained at 300 to 400 tmol/L ( Figure 3B) . However, the maximum activity was not significantly different from that found with a noninactivating lot of 2A2M1P ( Figure 3A ). Further addition of Zn2 above 600 imol/L resulted in enzyme inhibition similar to that shown for lot 7. Addition of Zn2 and Chelex treatment resulted in increased enzyme activity over the range of Zn2+ concentrations examined for both lots, although activity for lot 3 did not reach that maximally achievable. as the source of enzyme activity. Substitution of Co24, Ni2, or Cu24 for Zn24 addition to lot 3, followed by Chelex treatment, improved the enzyme stability in this preparation but not to the level achievable with Zn2. Chebex treatment of 2A2M1P without prior addition of Zn2+ had no measurable effect on enzyme activity in lots not showing significant inactivation. Addition of Chelex to lot 2 or 3 without addition of Zn2 caused a slight but significant decrease in activity and further reduced enzyme stability (over 35 mm) when compared with untreated 2A2MTP. The source of activity was pooled human serum; 100% = 169U/L. Sera were added to 2A2M1P solutions at 3000 and incubated for 20 mm; reactions were initiated by adding 4-nitrophenyl phosphate. Metal-ion spectral studies.
Since enzyme inactivation in 2A2M1P was thought to occur by complexing of Zn2, we examined three divalent metal ions that are also visiblewavelength spectral indicators: Cu2+, Ni2, and Co24. Similar spectra were found for lots 1 and 4-7, while aberrant spectra were given by the two lots (2 and 3) showing enzyme inactivation. Both the magnitude of the spectral shift to higher wavelength and the increased absorbance correlated with the ability to inactivate.
With Cu24, the most sensitive indicator, maximum absorbance for lots 1 and 4-7 was at 525 nm; maximum absorbance for lots 2 and 3 was between 580 and 600 nm ( Figure   5 ).
The ratio A595/A525 of the Cu24-compbex and the relative WAVELENGTH (nm) alkaline phosphatase activity were determined for all seven lots of 2A2M1P ( Table 1 ). The squared correlation coefficient (r2) between increased absorbance ratio and decreased activity was 0.980. The correlation between enzyme activity and A595/A525 for these lots and 14 additional 2A2M1P preparations is shown in Figure 6 . These data indicate that the Cu24-compbex absorbance spectrum is reliable in predicting the presence and amount of inhibitor.
The effect of Zn24 on the formation of the characteristic Cu24-complex absorbance spectrum found in the presence of inactivator is shown in Figure 7 . The decreased absorbance at 550-700 nm suggests that Zn24 also interacts with the impurity, which gives rise to the absorbance peak near 595 nm in the presence of Cu24. Addition of Zn24 alone did not affect the spectrum at 400-800 nm.
Addition
of Zn24 followed by Chelex treatment also decreased the absorbance of the Cu24 complex at 550-700 nm with lot 3. Addition of Zn2 did not significantly influence the spectrum with lots not containing an inactivator. Amberlite CG-120 cation-exchange and Bio-Rad (Dowex) AG 1-X2 anion-exchange resins were added at 20 g per 100 mL of representative lots of 2A2M1P (900 mmol/L, pH 10.5). The mixtures were gently shaken overnight and then allowed to set for >24 h, with occasional shaking, at room temperature. The supernatant 2A2M1P solution was carefully decanted and filtered through 0.22-tm filters. The pH of Amberlite-treated materials increased to 11.15 ± 0.05 and was readjusted to 10.5 with concentrated HCI. The Cu24-2A2M1P absorbance spectra and alkaline phosphatase activity with these solutions were determined.
With satisfactory lots of 2A2M1P, as represented by lots 7 and 4, these treatments resulted in no difference in activity or in the absorption spectrum of the Cu2+_complex. However, with lots 2 and 3, AG 1-X2 resin caused a modest increase in enzyme activity and a concomitant decrease in A595/A525. Amberlite treatment produced a spectrum very similar to those for uncontaminated lots and a marked increase in enzyme activity. Typical results are shown in Figure 8 .
Effects of selected organic compounds on enzyme activity.
Ten compounds, added to give the indicated concentrations WAVELENGTH (nm) Fig. 8 . Effect of anion and cation exchangers on Cu2-2A2M1P spectrum and alkaline phosphatase activity ina contaminated lotof 2A2M1P
Conditions for absorbance spectra as described in Figure 7 . Alkaline phosphatase activity determined as described in Materials and Methods; 4-nitrophenyl phosphate was used to initiate the reaction after 30-mm incubation of 2A2M1P and serum at 30#{176}C to lot 7 (900 mmob/L, pH 10.5), had no influence on alkaline phosphatase stability or on the Cu24-complex absorbance spectrum. These compounds (mmol/L) were: 2-dimethylamino-2-methyl-1-propanol (40), 2-methylamino-2-methyl-1-propanol (40), 2-nitro-2-methyl-1-propanol (40), diphenylamine (5), diethanolamine (25) , NH4OH (1), KCN (1), 2-amino-2-methyl-1,3-propanediol (40), NaBH4 (20) , and formaldehyde (40) . Methylamine at an assay concentration of 2.7 mmol/L produced a 45% inhibition of human serum and liver alkaline phosphatase.
This inhibition was not dependent upon incubation time nor on the mode of initiation of the reaction. Methybamine at this concentration did not affect the absorbance spectrum of the Cu2+ complex. EDTA at all concentrations was inhibitory to the enzyme and increased the A595/A525 of the Cu2+ complex; however, the absorbance of the complex was significantly reduced. Phthalic acid at 10 mmol/L produced over 70% inhibition of the enzyme, but this inhibition was not dependent upon incubation time. Phthalate at this concentration had no significant effect on the absorbance of the Cu24 complex. Ethylenediamine at 40 mmol/L produced a 24% inhibition of enzyme activity after 10-mm incubation at 30#{176}C. This inhibition was time-dependent and was reversible by addition of Zn24. Ethylenediamine shifted the absorbance spectrum of the Cu2+ complex to a maximum of 550 nm and resulted in an intense absorbance peak.
Characterization of AATMH as an Enzyme Inhibitor and 2A2M1P Contaminant
The reaction scheme used to prepare 2A2M1P suggests that AATMH may be a likely byproduct and contaminant (see Discussion), which could chelate divalent metal ions. We therefore examined its effects on alkaline phosphatase activity and the Cu24 spectrum. AATMH at trace levels (<0.05% on a molar basis) influenced enzyme activity in the same timedependent manner, reversible by addition of Zn24, as the endogenous contaminant in 2A2M1P ( Table 2 ). The Cu24 spectrum was also influenced in the same manner: an increase in absorptivity and a shift to higher wavelengths with increased concentration ( Figure 9) . The values for enzyme activity and A595/A525 correlated well with the concentration of AATMH (Figure 10 ).
Liquid chromatography of 2A2M1P, with ultraviolet detection at 205-210 nm, was not sufficiently sensitive to detect AATMH, whether added in trace amounts to 2A2M1P or endogenous in contaminated lots. The limit of detectability was about 0.5 mol per 100 mol. To improve sensitivity, we exploited the chelating properties of AATMH: reversed-phase liquid chromatography was performed in the presence of Cu2+, with photometric detection of Cu24 complexes at 580 nm ( Figure 11 ). Chromatographic separation of chloroform extracts of lots 2 and 3 revealed a peak with a retention time identical to that of the Cu24-AATMH complex; extracts of
WAVELENGTH (nm)
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intense, bands were detected in dansylated extracts of lots 5 and 7. We tentatively attributed the three bands found for dansylated AATMH to the didansyl and two possible monodansyl derivatives of AATMH. Lot 3 also exhibited numerous additional dansyl derivatives.
Infrared and Fourier-transform infrared spectra of contaminated and noncontaminated lots of 2A2M1P were essentially identical. AATMH spectra were also very similar to those of 2A2M1P. Ultraviolet-visible spectra of the seven lots differed considerably, but the differences did not correlate with depression of enzyme activity. Mass spectroscopy and gas chromatography/mass spectrometry of contaminated and noncontaminated lots revealed no molecular ions that could not be attributed to 2A2M1P. The mass spectrum of AATMH, The stabilities of alkaline phosphatases from various sources were determined from the slope of activity decrease with increasing concentration of AATMH. Ten concentrations of AATMH were used (0 to 4 mmol/L), and the enzymes were incubated for 7.5 mm at 30 #{176}C. Stability followed the order: human placenta >> human liver porcine kidney : bovine liver calf kidney human serum pool> calf intestine human intestine. To further examine the mechanism of action of AATMH, we incubated serum enzyme for 10 mm at 30#{176}C with a reaction mixture containing AATMH at 4 mmol/L. The reaction was initiated by adding 4-nitrophenyl phosphate, and after 3 mm Zn24 was added to give a concentration of 0.16 mmol/L. A 26% increase in measured activity was observed.
AATMH was added at 5 mmob/L to five buffers: 2A2M1P (900 mmol/L, pH 10.5), diethanolamine (900 mmolfL, pH 10.5), Tris (900 mmol/L, pH 10.5), CAPS (250 mmol/L, pH 10.5), and CAPS plus NaC1 (650 mmol/L). Pooled human serum alkaline phosphatase was added to these solutions, and its stability was examined over a 5-mm period at 30 #{176}C. The following decreases in enzyme activity were observed: 2A2M1P, 28%; diethanolamine, 18%; Tris, 19%; CAPS, 4%; CAPS plus NaC1, 9%.
In addition to the chloroform extraction described above, we performed extractions according to the protocol of Derks et al. (15) . With lot 3 of 2A2M1P this treatment increased alkaline phosphatase activity by 61%, but the activity was only 78% of that measured with a noncontaminated lot. Chloroform was measured at 8 g/L (67 mmol/L) in the resulting 2A2M1P solution. Significant amounts of 2A2M1P were detected in the chloroform extracts by liquid chromatography (detection at 205 nm) or by preparation of dansyl derivatives.
Discussion
The sources of contamination of reagents used in enzyme assays are manifold (5, 25) . Publications from a number of laboratories (3, (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) reporting preparations of 2A2M1P that inactivate alkaline phosphatase suggest that contamination originates in the production of 2A2M1P rather than through spurious causes.
2A2M1P is synthesized by the condensation of 2-nitropropane with formaldehyde (26, 27) to form 2-methyl-2-nitro-1-propanol (2M2N1P), which is subsequently reduced over Raney nickel to produce 2A2M1P:
We therefore examined the compounds used in the synthesis of 2A2M1P or produced by side reactions in its synthesis:
formaldehyde, 2M2N1P, 2-dimethylamino-2-methyl-1-propanol, and 2-methylamino-2-methyl-1,3-propanediol. None of these, at contaminant concentrations, affected either alkaline phosphatase activity or the Cu24-2A2M1P absorbance spectrum as does the endogenous mactivator.
Formation of a secondary amine condensation product is possible by the reaction of the nitro alcohol 2M2N1P with the amino alcohol 2A2M1P (27, 28) to form 3-aza-5-nitro-2,2,5-trimethylhexanol (ANTMH):
ANTMH This is a likely reaction, because both 2M2N1P and 2A2M1P are present in the reaction mixture during production of 2A2M1P. If ANTMH is formed, it is subsequently reduced to AATMH by the same Raney nickel hydrogen procedure used to reduce 2M2N1P to 2A2M1P (27, 28) :
ANTMH AATMH
Our results show that AATMH behaves identically to the endogenous inhibitor in 2A2M1P in its time-dependent inactivation of alkaline phosphatase, its effect on the Cu24 complex absorbance spectrum, the reversibility of its effects by Zn24, and the retention times and migration rates of the native and dansylated compounds (Figures 3,5,6 , 10, and 11, and Table   2 ). Small but detectable amounts of dansyl-AATMH were also observed in noncontaminated lots of 2A2M1P ( Figure 12 ). Mass spectrometry and Fourier-transform infrared spectroscopy confirmed that the contaminant occurs at low concentrations (<1.0 mol/100 mol) and is structurally similar to 2A2M1P.
The action of AATMH as a contaminant metal chelator was further confirmed when Chelex treatment of lots 2 and 3 of 2A2M1P resulted in further reduced enzyme activity. We ascribed this effect to the removal of endogenous Zn24 from solution. We have previously shown that commercial preparations of 2A2M1P contain Zn and other divalent metal ions in trace amounts (10, 17) . The detection of AATMH in what we have called (on the basis of depression of enzyme activity) non-contaminated lots indicates that AATMH is present in most preparations of 2A2M1P, but that its effects are blocked or minimized by the presence of 2+ or other divalent metals, or both.
The results of adding AATMH to buffers other than 2A2M1P suggest a synergistic effect with other amino groups, since inactivation in CAPS buffer was significantly decreased as compared with 2A2M1P, diethanolamine, or Tris. We considered the metal-binding properties of the amino buffers themselves (29, 30) to be responsible for this.
Reactivation of the enzyme by zinc in the presence of AATMH after the reaction has been initiated suggests that AATMH chelates the zinc atom involved in the catalytic reaction ("loose zinc"), rather than the atom that maintains the structure of the enzyme ("tight zinc"). Removal of the structural zinc atom from alkaline phosphatase leads to an unstable enzyme, which is readily and irreversibly denatured (24, 31, 32) .
In studies with both the contaminated lots of 2A2M1P and uncontaminated lots to which AATMH was added, we found considerable variability in the degree of inactivation dependent upon the length of incubation, the endogenous trace levels of Zn2+ or other metal ions, the presence of substrate, and the source of the enzyme. Because of these variables, quantitation of AATMH as an endogenous inactivator in 2A2M1P on the basis of enzyme stability alone is difficult. Although intestinal enzyme is the most sensitive indicator, variations in its metal ion status would greatly affect enzyme stability. These limitations are most apparent with the use of quality control sera, where the enzyme is often not fully saturated with Zn24 (33) . Therefore the use of such materials to quantitate effects of inactivator in 2A2M1P (14) cannot easily be extended to studies with human serum.
As an alternative, Cu24 can be used as a spectral probe of metal-ion chelators-in particular AATMH. The complex formed between amines, including 2A2M1P, and Cu24 (30, 34, 35) can he exploited to detect the presence of other amine compounds. The efficacy of Cu24 as a spectral indicator of Zn24-binding in 2A2M1P is confirmed by the significant shift in the absorbance spectrum when Zn2+ was added in the presence of Cu24. The A595/A525 of the Cu24 complex with endogenous and exogeneous inactivator correlated well with the loss of enzyme activity ( Figures 5,6, 8,9 , and 10, Table 1 ). This procedure was, however, affected by the presence of Zn24, as was measured enzyme activity. Prior treatment of 2A2M1P with an excess of Chelex-100 removed this interference. We have found that this very simple, reliable test can easily be used to screen several lots of 2A2M1P in a short time. Our data suggest that lots with As9ilA5m = 0.95-1.0 should be suspect (borderline) and those with A595/A525 >1.0 should he discarded (unacceptable).
Most lots in our study were either borderline or unacceptable ( Figure 6 ). Extraction with chloroform has recently been recommended (15) for purifying 2A2M1P. Our data show that while chloroform may extract some contaminants for identification, substantial amounts of AATMH will remain in the aqueous phase. Furthermore, considerable amounts of 2A2M1P are also extracted, and unless a distillation step is introduced, the resulting concentration of 2A2M1P will be unknown. This procedure also leaves chloroform present at 67 mmol per liter of 2A2M1P.
Other means of eliminating the effect of metal chelators in 2A2M1P involve addition of Zn2 and controlling its free concentration by titration (14, 15) or addition of soluble (36) or insoluble (17) chelators. Although these are of practical value, we believe that eliminating the inactivator is preferable to compensating for its effects. Because the Mg24 binding site of alkaline phosphatase has a high affinity for Zn24 (37) , forming an inactive enzyme, the amount of Zn24 added must be strictly controlled. It must be sufficient to saturate the chelators without inhibiting the enzyme. The low activity found when Zn24 was added to lot 2 ( Figure 4 ) was due to an excess of Zn24 for this particular lot of 2A2M1P.
Interferents in enzyme analyses must be identified before they can be eliminated (5) . We have identified AATMH as such an interferent. To make 2A2M1P preparations that are satisfactory for assay of alkaline phosphatase activity, it could be incubated and distilled in the presence of butyl nitrite (38) . Fractional freezing may also be effective (39) . Because AATMH arises in the production rather than the degradation of 2A2M1P, materials prepared without AATMH should remain suitable for use after storage.
In addition to AATMH, all the commercial preparations tested (e.g., Figures 11 and 12 ) contained numerous contaminants, some capable of binding Cu24. Thus elimination of AATMH alone may not make 2A2M1P suitable for alkaline phosphatase assay. For example, by reaction schemes similar to those presented above, 2M2N1P could condense with AATMH to form 8-ammno-3,6-diaza-2,2,5,5,8-pentamethylnonanol, which by its structure would be expected to chelate metal ions.
We believe that AATMH is the compound that was partly characterized by Williamson and Thompson (11) as a substituted diamine. However, the structure that they proposed is consistent with AATMH only in the -N-C-C-Nlinkages. The degree of alkyl substitution of AATMH is far greater than they suggested (e.g., the N-hydroxymethylpropyl of AATMH was characterized as an N-methyl group in the earlier study).
By using the data in Figure 10 as a calibration curve, we estimate that the concentration of AATMH in lot 3 was about 0.03% on a molar basis, resulting in an assay concentration of about 300 jmol/L. Addition of Zn24 to give an assay concentration of about 300 imolfL restores full enzyme activity with this material ( Figure 3B ). This suggests a 1:1 complex between AATMH and Zn24.
Although 2A2M1P has been utilized in several recommended methods for alkaline phosphatase activity (1, 7, 18, 36, 40) and is widely used by clinical laboratories, relatively little attention has been directed to establishing criteria for its acceptability.
If 2A2M1P is still to be recommended, interferents such as the one described here must be systematically detected and eliminated.
Bowers et al. (2) have recently demonstrated the need to establish criteria for the components of the phosphatase reaction. They have shown that the use of substrate, 4-nitrophenyl phosphate, from various sources gives rise to a large variability in the measurement of enzyme activity. To achieve 98% activity they suggest limits for inorganic phosphate and 4-nitrophenol contamination of 1.0 and 0.3% (on a molar basis) respectively. By this criterion the contamination of 2A2M1P
by AATMH must beheld to <0.001% on a molar basis. We are now investigating methods to achieve this goal.
